Q4 2024 Earnings Call Transcript March 4, 2025 Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals Fourth Quarter 2024 Financial Report and Company Update. This call is being recorded ...

NASHVILLE, Tenn., Feb. 25, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its annual 2024 financial ...

Cumberland's management believes these supplemental financial performance measures are important as they are used by management, along with financial measures in accordance with GAAP, to evaluate ...

Good afternoon, and welcome to the Cumberland Pharmaceuticals fourth quarter 2024 financial report and company update. This call is being recorded at the company's request and will be archived on ...

(a) Represents the share-based compensation of Cumberland. Adjusted Diluted Earnings Per Share: Adjusted loss divided by diluted weighted-average common shares outstanding.

Good afternoon, and welcome to Cumberland Pharmaceuticals Fourth Quarter 2024 Financial Report and Company Update. This call is being recorded at company’s request and will be archived on its ...